Jubilant Cadista Pharmaceuticals, Inc. recalls clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuti…
- Recall date
- November 6, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0104-2021
- FDA classification
- Class II
- Brand / firm
- Jubilant Cadista Pharmaceuticals, Inc.
- Sold / distributed
- Product was distributed nationwide.
Why it was recalled
Failed Tablet/Capsule Specification
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD NDC 59746-711-30
Get recall alerts
Free email alert whenever Jubilant Cadista Pharmaceuticals, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Jubilant Cadista Pharmaceuticals, Inc.